U.S. Markets closed

Biogen soars as it seeks U.S. Alzheimer’s drug approval

Biogen shares are soaring after the pharma giant announced it would seek U.S. approval for its Alzheimer's treatment drug. Yahoo Finance's Akiko Fujita and Anjalee Khemlani discuss on The Ticker.